You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Ciprofloxacin In Dextrose 5% In Plastic Container patents expire, and when can generic versions of Ciprofloxacin In Dextrose 5% In Plastic Container launch?

Ciprofloxacin In Dextrose 5% In Plastic Container is a drug marketed by Baxter Hlthcare, Baxter Hlthcare Corp, Bedford, Hikma Farmaceutica, Hospira, Inforlife, and Teva Pharms. and is included in seven NDAs.

The generic ingredient in CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER is ciprofloxacin. There are thirty-four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ciprofloxacin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Ciprofloxacin In Dextrose 5% In Plastic Container

A generic version of CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER was approved as ciprofloxacin by BAXTER HLTHCARE CORP on April 29th, 2008.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER?
  • What are the global sales for CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER?
Summary for CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Drug patent expirations by year for CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Recent Clinical Trials for CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Institute of Cancer Research, United KingdomPhase 1/Phase 2
Prostate Cancer FoundationPhase 1/Phase 2
Shanghai Pulmonary Hospital, Shanghai, ChinaPhase 4

See all CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER clinical trials

Pharmacology for CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER

US Patents and Regulatory Information for CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER ciprofloxacin INJECTABLE;INJECTION 077888-001 Mar 18, 2008 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma Farmaceutica CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER ciprofloxacin INJECTABLE;INJECTION 078431-001 Nov 18, 2009 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Baxter Hlthcare Corp CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER ciprofloxacin INJECTABLE;INJECTION 078024-002 Mar 18, 2008 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Pharms CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER ciprofloxacin INJECTABLE;INJECTION 077138-001 Mar 18, 2008 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER ciprofloxacin INJECTABLE;INJECTION 077753-001 Mar 18, 2008 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Baxter Hlthcare CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER ciprofloxacin INJECTABLE;INJECTION 077888-002 Mar 18, 2008 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.